Position in MRK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,079,258
+$128,757 QoQ
Shares Held
16,181
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#1,559
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlas Brown,Inc. holds $23,716,828 across 9 Drug Manufacturers - General names. MRK ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,094 | $8,150,913 | |
| 2 | ABBV |
AbbVie Inc.
|
30,004 | $7,550,205 | |
| 3 | LLY |
ELI LILLY & Co
|
2,009 | $2,409,654 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
16,181 | $2,079,258 | |
| 5 | PFE |
Pfizer Inc
|
80,876 | $1,947,493 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,373 | $770,551 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,508 | $443,200 | |
| 8 | GSK |
GSK plc
|
4,053 | $212,458 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,079,258 | 16,181 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $1,950,501 | 16,215 | Shares | Defined | 2026-04-17 | |
| 2025-12-31 | $1,705,632 | 16,204 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $1,359,330 | 16,196 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $1,277,484 | 16,138 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,435,711 | 15,995 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,619,633 | 16,281 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $1,779,258 | 15,668 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,931,032 | 15,598 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,169,126 | 16,439 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $1,689,810 | 15,500 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,602,107 | 15,562 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $1,786,929 | 15,486 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,646,917 | 15,480 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,694,650 | 15,274 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $1,555,585 | 18,063 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $1,638,598 | 17,973 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,459,587 | 17,789 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,362,352 | 17,776 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,308,716 | 17,424 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,350,398 | 17,364 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $1,337,666 | 17,352 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $1,342,909 | 16,417 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,336,325 | 16,110 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,260,402 | 16,299 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,088,700 | 14,150 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||